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A amiloidose traqueobrônquica primária é uma for-
ma de amiloidose respiratória, caracterizada pela pre-
sença de depósitos insolúveis de proteína fibrilar ami-
lóide, ao longo da parede das vias aéreas. É uma 
doença pouco frequente, sendo necessário uma amos-
tra de tecido para estabelecer o diagnóstico definitivo, 
com base em características histológicas específicas.
Os autores relatam dois casos clínicos de amiloidose 
traqueobrônquica, descrevendo os seus sintomas e os 
procedimentos diagnósticos e terapêuticos que foram 
efectuados.
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Abstract
Primary tracheobronchial amyloidosis is a form of 
respiratory amyloidosis, characterised by insoluble 
amyloid fibril proteins deposits along the airways 
wall. It is an uncommon disease, requiring a tissue 
sample to establish the definite diagnosis based on 
specific pathological features.
The authors report two cases of tracheobronchial 
amyloidosis, describing their symptoms and the diag-
nostic and therapeutic procedures that were per-
formed.
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Introduction
Amyloidosis includes a group of diseases 
characterised by the extracellular deposit of 
fibrillar protein in one or more organs. 
Amyloidosis can be localised or systemic, 
according to the anatomic involvement, and 
primary or secondary, in this last case if as-
sociated with chronic inflammatory or in-
fectious diseases or neoplasms. Primary res-
piratory amyloidosis is uncommon and can 
involve the tracheobronchial tree (in a focal 
or diffuse way) or the pulmonary parenchy-
ma (as multiple nodules or diffuse intersti-
tial infiltrate).
In tracheobronchial amyloidosis, symptoms 
such as dyspnoea, cough, hoarseness, hae-
moptysis, wheezing or stridor can be pre-
sent, due to bronchial obstruction.
The authors describe two cases of localised 
tracheobronchial amyloidosis with distinct 
clinical features and management ap-
proach.
Case 1
A 68 year-old female nonsmoker presented 
with hoarseness, stridor and progressive dys-
pnoea for the last four months. The patient 
had cleft palate and a past history of arterial 
hypertension and cerebrovascular disease, 
with no neurological sequelae. She had 
worked as a dressmaker, and retired 3 years 
ago. On physical examination, she had res-
piratory distress, with stridor audible over 
the trachea. At laryngeal observation, oede-
ma and irregularity of glottic and infra-glot-
tic region were recognised. Full blood count, 
biochemical and arterial blood gases (while 
breathing room air) analysis were within 
normal values. Chest radiography showed 
no abnormalities. Computed tomography 
of the chest showed circumferential wall 
thickening of the trachea and the main bron-
chi, with no relevant lung parenchyma ab-
normalities (Fig. 1). Pulmonary function 
tests revealed the following values (as % pre-
dicted): FVC: 101%, FEV1: 87%; FEV1/
FVC: 71%; PEF: 48%; FEF 25-75: 58%; 
FEF 50: 53%; FEF 75: 76%; VC: 96%; 
TLC: 87%; RV: 86%; RV/TLC: 41%.
Subsequently, the patient underwent fi-
beropticbronchoscopy, which documented, 
besides great deformation of ari-epiglottic 
folds and glottis, mucosal irregularity along 
the trachea and both proximal bronchial 
trees. There were several mucosal and sub-
mucosal yellowish lesions, some of which 
were flat and some were projecting from the 
tracheal wall to the tracheal lumen. Since 
two mucosal prominences, most evident in 
infra-glottic region, determined significant 
obstruction, the patient was submitted im-
mediately to rigid bronchoscopy. During 
this procedure, mechanical dilatation was 
performed, followed by insertion of a stent 
(Dumon, 16/30 mm) in the upper tracheal 
portion. At this time, biopsies from the in-
fra-glottic lesions were obtained. When she 
Fig. 1 – Thoracic CT scan: circumferential wall thickening of the 
main bronchi
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woke up from the intervention, she no lon-
ger presented stridor, and a few hours later 
she was discharged from the hospital. How-
ever, four days later, the patient returned to 
our department complaining of acute onset 
of stridor and dyspnoea. Fiberopticbron-
choscopy showed distal migration of the 
tracheal stent, causing partial obstruction in 
the distal third of the trachea. The stent was 
removed by rigid bronchoscopy. After these 
procedures a significant increase in the tra-
cheal lumen was obtained and the patient 
totally recovered from her symptoms, and 
has been clinically stable since then.
Histopathological result of tracheal biopsy 
revealed extensive deposit of an amorphous 
and eosinophilic substance in the corion, 
with green birefringence on Congo red 
stain, confirming the diagnosis of amyloi-
dosis (Fig. 2).
Presence of Bence Jones proteins in urine 
was excluded. Serum protein electrophore-
sis was normal, as well as the electrocardio-
gram and the echocardiogram.
From the bronchoscopy procedure until 
now (30 months later), the patient remained 
clinically well, with neither stridor nor dys-
pnoea and without the need of any bron-
chodilator or anti-inflammatory therapy. 
Follow-up lung function shows stability.
Case 2
A 62 year-old female nonsmoker presenting 
one-year history of hoarseness and dyspnoea 
was sent for evaluation at bronchoscopy unit 
for exclusion of tracheobronchial amyloidosis. 
She was previously observed at the Otorhino-
laryngology department where indirect laryn-
goscopy was performed. A right ari-epiglottic 
fold deformation and erythema in the poste-
rior third of the right vocal cord, with a suspi-
cious granuloma in the posterior commissure 
were seen. Biopsy of these lesions confirmed 
the presence of extensive corion occupation by 
an eosinophilic, hyaline and green birefrin-
gence material to polarised light, after Congo 
red stain, consistent with laryngeal amyloido-
sis. Fiberopticbronchoscopy showed mucosal 
oedema with yellow-coloured plaques scat-
tered along tracheal and main bronchi anterior 
wall (Fig. 3 and 4). These lesions did not cause 
any obstruction and were biopsied. Tracheo-
bronchial amyloidosis has also been confirmed. 
Chest radiography was normal and thoracic 
computed tomography scan did not show any 
Fig. 2 – Histopathological exam: extensive deposit of an amor-
phous and eosinophilic substance in the corion
Figs. 3 and 4 – Several mucosal and submucosal yellow-colored plaques scattered along tracheal 
and main bronchi anterior wall
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tracheobronchial airway or pulmonary paren-
chyma abnormalities. Her pulmonary func-
tion test had the following values (as % pre-
dicted): FVC: 115%; FEV1: 105%; FEV1/
FVC: 76%; PEF: 91%; FEF 25-75: 67%; 
FEF 50: 86%; FEF 75: 41%; VC: 111%; 
TLC: 94%; RV: 81%; RV/TLC: 35%.
Systemic amyloidosis was excluded by per-
forming an abdominal fat biopsy, echocar-
diogram, serum protein electrophoresis and 
detection of Bence Jones proteins in urine, 
which were all negative.
Discussion
Amyloidosis consists in extracellular accumula-
tion of insoluble protein, which results from the 
misfolding of fibril precursor proteins1,2. It en-
compasses a group of diseases, classified accor-
ding to fibril precursor protein, including pri-
mary systemic amyloidosis, reactive systemic 
amyloidosis related with hereditary or acquired 
chronic inflammatory diseases (for instance, 
rheumatoid arthritis and chronic infections), 
systemic amyloidosis associated with monoclo-
nal gammopathy or myeloma, Alzheimer’s di-
sease, type II diabetes mellitus and localised 
forms of amyloid deposit in single organs3.
Amyloidosis may involve different portions 
of the pulmonary tract, occurring in one of 
three forms, namely, tracheobronchial, dif-
fuse interstitial pulmonary infiltrates and 
single or multiple pulmonary nodules3, 4, 5.
Fiberopticbronchoscopy is useful because it 
can reveal yellow-coloured submucosal 
plaques, which suggest the diagnosis and, at 
the same time, it allows the performance of 
a tissue biopsy, which is necessary to con-
firm the diagnosis.
The management approach of patients with 
tracheobronchial amyloidosis depends on their 
symptoms. Bronchoscopy debulking or laser 
resection is required in some patients with rele-
vant airway obstruction5,6,7,8,9. As we described, 
a successful and stable result was obtained in 
our first patient, who underwent bronchoscop-
ic dilatation, with mechanical resection of obs-
tructive amyloid deposits, followed by place-
ment of an endotracheal stent. Sometimes 
bronchoscopic debulking must be repeated be-
cause amyloid deposits tend to recur9. However, 
in our patient a successful removal of tracheal 
amyloid deposit was achieved, with normal air-
way patency in such a way that the stent had to 
be subsequently removed. On the other hand, 
in asymptomatic patients or in those with few 
symptoms and with no airway compromise, as 
was the case of our second patient, an observa-
tional attitude may be the best option7.
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